SPOTLIGHT: Iraqi-bribe probe touches Glaxo, AZ

The feds are shining a spotlight on drug makers suspected of bribing Saddam Hussein's regime. Allegedly, the pharma companies wanted a piece of the oil-for-food action, which allowed petrol money to pay for humanitarian goods--such as drugs. GlaxoSmithKline and AstraZeneca are among those asked for documents related to those sales; the companies deny wrongdoing. Report

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.